165 related articles for article (PubMed ID: 15192465)
21. Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.
Salamon J; Derlin T; Bannas P; Busch JD; Herrmann J; Bockhorn M; Hagel C; Friedrich RE; Adam G; Mautner VF
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):685-92. PubMed ID: 23232507
[TBL] [Abstract][Full Text] [Related]
22. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
24. Tc-99m MDP uptake in retroperitoneal malignant peripheral nerve sheath tumor and its metastases.
Li L; Kuang A; Sheng S
Clin Nucl Med; 2006 Jan; 31(1):44-5. PubMed ID: 16374127
[TBL] [Abstract][Full Text] [Related]
25. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
[TBL] [Abstract][Full Text] [Related]
26. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR
Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623
[TBL] [Abstract][Full Text] [Related]
27. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C
Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584
[TBL] [Abstract][Full Text] [Related]
28. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature.
Yu YH; Wu JT; Ye J; Chen MX
World J Surg Oncol; 2016 May; 14():142. PubMed ID: 27159980
[TBL] [Abstract][Full Text] [Related]
29. A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
Otomi Y; Otsuka H; Morita N; Terazawa K; Harada M; Nishitani H
J Med Invest; 2009 Feb; 56(1-2):76-9. PubMed ID: 19262018
[TBL] [Abstract][Full Text] [Related]
30. Case Report: Metastasis of a Trigeminal Malignant Peripheral Nerve Sheath Tumor to the Corpus Callosum.
Shutran M; Mosbach D; Tataryn Z; Arkun K; Wu JK
Neurosurgery; 2019 Jan; 84(1):E63-E67. PubMed ID: 29518229
[TBL] [Abstract][Full Text] [Related]
31. Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.
Salamon J; Papp L; Tóth Z; Laqmani A; Apostolova I; Adam G; Mautner VF; Derlin T
PLoS One; 2015; 10(12):e0143305. PubMed ID: 26625155
[TBL] [Abstract][Full Text] [Related]
32. Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.
Luna R; Fayad LM; Rodriguez FJ; Ahlawat S
Skeletal Radiol; 2021 Jan; 50(1):201-215. PubMed ID: 32699955
[TBL] [Abstract][Full Text] [Related]
33. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P
Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
[TBL] [Abstract][Full Text] [Related]
35. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
Malerba M; Garofalo A
Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
[TBL] [Abstract][Full Text] [Related]
36. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
Sanchez D; Zudaire JJ; Fernandez JM; Lopez J; Arocena J; Sanz G; Gimenez M; Rosell D; Robles JE; Berian JM
BJU Int; 2002 Jun; 89(9):912-6. PubMed ID: 12010239
[TBL] [Abstract][Full Text] [Related]
37. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
38. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
39. [18-FDG-PET in a case of recurrent malignant schwannoma].
Santaella Y; Borrego I; López J; Ortiz MJ; Vázquez R
Rev Esp Med Nucl; 2005; 24(2):127-30. PubMed ID: 15745683
[TBL] [Abstract][Full Text] [Related]
40. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
